New Delhi, Oct. 9 -- Rubicon Research initial public offering (IPO) is all set to open for subscription today, Thursday, October 9. The mainboard issue will remain till Monday, October 13.

Rubicon Research is a pharmaceutical formulations company that emphasizes research, development, and innovation. Its portfolio features an expanding range of specialty medicines and drug-device combination products, with a strong focus on regulated markets, particularly the United States.

The subscription status of Rubicon Research IPO will begin at 10:00 am on Thursday, October 9.

Brokerage firm Arihant Capital has given 'subscribe' rating, said, "Rubicon Research Ltd is an integrated pharmaceutical product development company with a strong presence...